SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Novo Nordisk Rebrands As 'Novo', Announces Cultural Reset

Sept 14 - Novo Nordisk is changing its day-to-day name to 'Novo', and taking a ⁠new approach to company culture as it looks to claw back ground ⁠in the fierce obesity...

Lilly Says Foundayo Has Captured Over 30% Of New US patients on Oral Weight-loss Drugs

Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for ⁠oral obesity treatments, narrowing the early lead gained by Danish rival Novo...

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic therapies...

Obesity Runs in the Family. Here’s How to Stop It

Epigenetic transgenerational inheritance influences future generations. With continued exposure, the susceptibility to obesity and its associated comorbidities will threaten future generations.

Testosterone Scripts for Women Rise, Along With Denials and Delays

Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to...

Food Tracking for Weight Loss: More Tracking, More Loss

In a study of 5132 app users, higher food tracking frequency was associated with greater weight loss, with more than 70% losing at least 5% of their body weight at 6 months.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Latest News

Sept 14 - Novo Nordisk is changing its day-to-day name to 'Novo', and taking a ⁠new approach to company culture as it looks to claw back ground ⁠in the fierce obesity...

Eli Lilly on Monday said it has captured more than 30% of new patients in the U.S. market for ⁠oral obesity treatments, narrowing the early lead gained by Danish rival Novo...

Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administration to establish clear safety and access standards for psychedelic therapies...

Epigenetic transgenerational inheritance influences future generations. With continued exposure, the susceptibility to obesity and its associated comorbidities will threaten future generations.

Women increasingly turning to testosterone therapy to manage menopause symptoms are running into unexpected prescription delays and denials at pharmacies, according to...

In a study of 5132 app users, higher food tracking frequency was associated with greater weight loss, with more than 70% losing at least 5% of their body weight at 6 months.

News All Time

High Semaglutide Dropout Rates Signal Adherence Challenge

With nearly half of patients discontinuing semaglutide within 12 months — especially younger adults — clinicians face a growing challenge in sustaining long-term treatment.

Menopausal Symptoms Worse in Women With Type 2 Diabetes

An observational study finds a higher number of symptoms and greater severity among midlife women with type 2 diabetes than among those without.

Weekly Basal Insulin + Semaglutide Combo May Benefit T2D

Novo Nordisk’s phase 3b trial shows once-weekly IcoSema improves glycemic control and weight with less hypoglycemia than insulin glargine U100 in adults with type 2 diabetes.

Soccer-Spanish FA Launches Fertility Support Programme for Female Players and Referees

Spain's football federation has unveiled an agreement to support fertility treatment for female players and referees, presenting the measure as another way to give women in...

Midwifery Goes Beyond Birth: What Is Still Overlooked?

Midwives’ roles extend across reproductive, pregnancy, postpartum, pelvic floor, and community care, but cultural, structural, and professional barriers can limit their practice.

Ultrasound May Help Predict Graves Orbitopathy Risk

Researchers test a new risk score using ultrasound to screen for orbitopathy, a complication estimated to occur in more than 25% of people with Graves disease.

RET Fusion Linked to Occult Lymph Node Metastasis in PTC

A machine learning model uses independent risk factors to identify occult lymph node metastasis in clinically lymph node negative papillary thyroid cancer.

Tirzepatide Beats Semaglutide for Weight Loss, Not Safety

Tirzepatide may provide greater weight loss than semaglutide in adults with overweight or obesity, but this advantage comes at the cost of a higher risk for serious adverse events.

More Children Under 12 in US Are Being Prescribed Weight-loss Drugs, Study Finds

Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors ⁠seek new, effective treatments for younger...

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Novo Nordisk said on Monday it had halted two ⁠additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's ⁠efforts to...

MicroRNA Panel May Predict Early Liver Metastasis in PDAC

A machine learning model using 7 exosomal microRNAs can identify patients with pancreatic ductal adenocarcinoma at risk for early liver metastasis.

Can a Smoothie Boost GLP-1 Naturally?

Certain foods and products can support individuals taking GLP-1s for weight management, but they can’t boost GLP-1 production or be used rather than medications.

Metyrapone Linked to Improved Quality of Life in Cushing

Metyrapone is associated with progressive improvements in quality of life among patients with Cushing syndrome, with recovery timing and patterns varying across symptom domains.

How to Help Manage Depression After GLP-1 Weight Regain

Offer realistic expectations when medication use ends and provide the tools to remain on track.

Indian Activists Lodge Concerns About Food Warning Proposal

Activists spearheading calls for food labelling said a government proposal to have red warnings only when two concerning nutrients are high created ⁠an "industry-friendly loophole".

EMA Probes Injectable Iron Medicines for Bone Risks

European regulators launched a safety review of injectable iron medicines following reports of severe hypophosphatemia and osteomalacia.

Recommended News For You

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

The need for more Latinx participants in Alzheimer's trials is urgent.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

In 18 States, alcohol exclusion laws are still in effect.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

Recommended Articles For You

Magnetically Controlled Surgical Microdevices for Targeted Hematologic Tissue Intervention 

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease 

Understanding Neutrophilia: Causes, Symptoms, and Treatment Options 

Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Research discovery halts childhood brain tumor before it forms

2.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

3.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

4.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

5.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

1.

Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025

2.

AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance

3.

Preventing Sarcopenia During Cancer Treatment

4.

Guidance for Managing Complex Anticoagulation

5.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Updates on Standard V/S High Risk Myeloma Treatment

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot